FDA approves Medtronic's Artificial Intelligence Algorithms for Cardiac Monitoring

Medtronic, (headquartered in Dublin, Ireland), the global leader in medical technology, announced U.S. Food and Dru...

July 29, 2021 | Thursday | News
Menarini Asia-Pacific strengthens men's health portfolio in China

Menarini Asia-Pacific Holdings Pte. Ltd., part of the Menarini Group, the world's largest Italian biopharmaceutical comp...

July 22, 2021 | Thursday | News
China supports global polio endgame strategy with new vaccine

Sinovac Biotech, a leading provider of biopharmaceutical products in China, has received a drug registration approval fr...

July 19, 2021 | Monday | News
Frontier Biotechnologies launches two drug regimen for HIV

In conjunction with the IAS Conference on HIV Science, Germany's Frontier Biotechnologies has announced positive top-lin...

July 19, 2021 | Monday | News
Eisai launches bile acid transporter inhibitor Goofice in Thailand

Eisai's Thailand subsidiary Eisai (Thailand) Marketing Co., Ltd. has launched the bile acid transporter inhibitor Goofic...

July 19, 2021 | Monday | News
Jardiance (empagliflozin) approved in Europe for the treatment of heart failure

The European Commission has granted marketing authorization for Jardiance®(empagliflozin) as a treatment for adults ...

July 6, 2021 | Tuesday | News
Scientists propose repurposing anti-malarial drug Mefloquine to fight COVID-19

Japanese scientists are scanning the possibility of using an anti-malarial drug called mefloquine....

July 2, 2021 | Friday | News
eTheRNA, VUB expand collaboration to engineer next-generation mRNA therapeutics

eTheRNA immunotherapies, a clinical-stage company developing mRNA-based immunotherapies for the treatment of cancer and ...

June 23, 2021 | Wednesday | News
Vectura, Incannex to advance IHL-216A for treatment of traumatic brain injury

Vectura Group has signed an agreement with Australia-based Incannex Healthcare to provide pre-clinical development servi...

June 22, 2021 | Tuesday | News
RSF Bio enters worldwide license agreement with Sanofi for cardiovascular drug

Rancho Santa Fe Bio, Inc. (RSF Bio), a San Diego, California-based clinical-stage cardiovascular platform company, annou...

June 18, 2021 | Friday | News
Merck to commercialize Type 2 Diabetes drug in six growth markets

Merck has signed a collaboration agreement with Janssen Pharmaceuticals NV around the commercialization of INVOKANA...

May 4, 2021 | Tuesday | News
S. Korea's Peptron licenses global development of ADCs for cancer treatment

Peptron, Inc., a South Korea-based biotech company, and Qilu Pharmaceutical, a China-based pharmaceutical company f...

April 19, 2021 | Monday | News
BioVersys receives €20M in EU financing to support new antibiotics development

The European Investment Bank (EIB) and BioVersys AG, a clinical-stage pharmaceutical company developing treatments ...

April 14, 2021 | Wednesday | News
SK Biopharma seizures/epilepsy drug to launch in Europe

SK Biopharmaceuticals, Co., Ltd., a global innovative pharmaceutical company, announced that cenobamate received marketi...

April 5, 2021 | Monday | News
Australian oncology drug Paxalisib receives rights to develop and commercialize in China

Sydney-based Kazia Therapeutics Limited, an oncology-focused drug development company announced that it has entered into...

April 5, 2021 | Monday | News
Astellas launches XOSPATA (gilteritinib) in Singapore to treat adult Leukaemia patients

Astellas Pharma Inc. announced on March 31, 2021, that XOSPATA® (generic name: gilteritinib) is now available for pr...

March 31, 2021 | Wednesday | News
Eisai's Anti Cancer agent Lenvatinib-Pembrolizumab combo receives EMA in Japan

Eisai Co., Ltd. announced on March 30, 2021 that the European Medicines Agency (EMA) has confirmed it has acce...

March 30, 2021 | Tuesday | News
EirGenix's proposed Biosimilar 'Trastuzumab' shows positive Ph 3 results

EirGenix, Inc. announced that the Phase III clinical trial (Trial No.: EGC002, NCT03433313) of its breast cancer biosimi...

March 25, 2021 | Thursday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls